Your browser doesn't support javascript.
loading
Cellular communities reveal trajectories of brain ageing and Alzheimer's disease.
Green, Gilad Sahar; Fujita, Masashi; Yang, Hyun-Sik; Taga, Mariko; Cain, Anael; McCabe, Cristin; Comandante-Lou, Natacha; White, Charles C; Schmidtner, Anna K; Zeng, Lu; Sigalov, Alina; Wang, Yangling; Regev, Aviv; Klein, Hans-Ulrich; Menon, Vilas; Bennett, David A; Habib, Naomi; De Jager, Philip L.
Afiliación
  • Green GS; Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Fujita M; Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA.
  • Yang HS; Harvard Medical School, Boston, MA, USA.
  • Taga M; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Cain A; Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
  • McCabe C; Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA.
  • Comandante-Lou N; Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • White CC; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Schmidtner AK; Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA.
  • Zeng L; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Sigalov A; Edmond & Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Wang Y; Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA.
  • Regev A; Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA.
  • Klein HU; Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
  • Menon V; Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Bennett DA; Department of Biology, Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Habib N; Genentech, San Francisco, CA, USA.
  • De Jager PL; Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Irving Medical Center, New York, NY, USA.
Nature ; 633(8030): 634-645, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39198642
ABSTRACT
Alzheimer's disease (AD) has recently been associated with diverse cell states1-11, yet when and how these states affect the onset of AD remains unclear. Here we used a data-driven approach to reconstruct the dynamics of the brain's cellular environment and identified a trajectory leading to AD that is distinct from other ageing-related effects. First, we built a comprehensive cell atlas of the aged prefrontal cortex from 1.65 million single-nucleus RNA-sequencing profiles sampled from 437 older individuals, and identified specific glial and neuronal subpopulations associated with AD-related traits. Causal modelling then prioritized two distinct lipid-associated microglial subpopulations-one drives amyloidproteinopathy while the other mediates the effect of amyloid-ß on tau proteinopathy-as well as an astrocyte subpopulation that mediates the effect of tau on cognitive decline. To model the dynamics of cellular environments, we devised the BEYOND methodology, which identified two distinct trajectories of brain ageing, each defined by coordinated progressive changes in certain cellular communities that lead to (1) AD dementia or (2) alternative brain ageing. Thus, we provide a cellular foundation for a new perspective on AD pathophysiology that informs personalized therapeutic development, targeting different cellular communities for individuals on the path to AD or to alternative brain ageing.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Envejecimiento / Corteza Prefrontal / Biología Celular / Enfermedad de Alzheimer Límite: Aged80 Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Envejecimiento / Corteza Prefrontal / Biología Celular / Enfermedad de Alzheimer Límite: Aged80 Idioma: En Revista: Nature Año: 2024 Tipo del documento: Article País de afiliación: Israel